| 张翠红,林胜红,刘新荣,安树伟,高叶,黄硕,邓源,王丽萍,郑亚明.山西省大同市2017-2019年布鲁氏菌病患者医疗费用分析[J].中华流行病学杂志,2022,43(12):1965-1971 |
| 山西省大同市2017-2019年布鲁氏菌病患者医疗费用分析 |
| Medical costs of brucellosis patients in Datong of Shanxi province, 2017-2019 |
| 收稿日期:2022-01-04 出版日期:2022-12-17 |
| DOI：10.3760/cma.j.cn112338-20220104-00002 |
| 中文关键词: 布鲁氏菌病 卫生资源 医疗费用 并发症 |
| 英文关键词: Brucellosis Healthcare utilization Medical costs Complications |
| 基金项目:国家科技重大专项（2018ZX10713001-001） |
|
| 摘要点击次数: 1799 |
| 全文下载次数: 407 |
| 中文摘要: |
| 目的 分析山西省大同市布鲁氏菌患者的医疗费用及影响因素。方法 收集2017年1月1日至2019年12月31日期间诊断为布鲁氏菌病患者的人口学信息、就诊信息和费用信息。对患者3年内医疗资源使用情况和医疗费用进行分析；分析不同性别、年龄、基础性疾病、临床分期、并发症对患者医疗资源利用及医疗费用的影响。结果 共2 289例纳入分析，其中门诊1 715例，住院574例；男性占72.0%（1 649/2 289），年龄（49.6±15.5）岁，45~59岁年龄组为主（36.2%，829/2 289）。住院患者年龄（51.4±16.0）岁高于门诊（49.0±15.2）岁（Z=-4.01，P<0.001）。门诊患者年人均门诊次数（1.6±1.5）次。住院患者次均住院天数（14.6±9.9）d，患有中枢神经系统并发症［（20.8±11.4）d］和心血管系统和造血系统并发症［（16.6±9.5）d］的患者住院时间较长（均P<0.05）。在住院患者中，患有基础性疾病占51.0%（293/574），其中内分泌代谢疾病占30.3%（174/574）；急性期患者占54.0%（310/574），慢性期占46.0%（264/574）；患有并发症占64.3%（369/574），其中，消化系统、骨骼系统并发症分别占30.3%（174/574）和29.1%（167/574）。门诊患者中，年龄是医疗费用的影响因素（P<0.001）；住院患者中，年龄、并发症和疗效是医疗费用的影响因素（P<0.05），合并骨骼系统和中枢神经系统并发症的患者医疗费用高于无此二系统并发症者（P<0.001）。结论 2017-2019年山西省大同市布鲁氏菌病门诊病例的医疗费用负担尚可，住院患者特别是合并骨骼、神经系统并发症的患者其经济负担较重。病例的早发现、早诊断及早治疗，仍是避免并发症发生和进展，有效降低医疗费用的重要手段。 |
| 英文摘要: |
| Objective To explore the medical costs and influencing factors of patients diagnosed with Brucellosis in Datong of Shanxi province. Methods Information on demographics, medical visits, and costs of patients diagnosed with Brucellosis between January 1, 2017, and December 31, 2019, were collected. Health care utilization and medical costs were analyzed from different genders, age groups, underlying diseases, clinical stages, and comorbidities. Results A total of 2 289 patients (1 715 outpatient and 574 inpatient cases) were included in the analysis. 72.0% (1 649/2 289) were male, with an average age of (49.6±15.5) years; age between 45-59 years was the dominant group (36.2%,829/2 289). The mean age of inpatients (51.4±16.0) was higher than that of outpatients (49.0±15.2)(Z=-4.01, P<0.001). The average number of outpatient visits per outpatient was (1.6±1.5) times. The duration of hospitalization was (14.6±9.9) and (20.8±11.4) days for patients with central nervous system complications and (16.6±9.5) days for vascular system complications. Of the inpatients, 51.0% (293/574) had underlying diseases, and 30.3% (174/574) had endocrine and metabolic diseases. 54.0% (310/574) of inpatients were diagnosed with acute Brucellosis, and 46.0% (264/574) were diagnosed with chronic Brucellosis. A total of 64.3% (369/574) of inpatients had complications, 30.3% (174/574) of digestive system complications, followed by skeletal system complications (29.1%, 167/574). Among outpatients, age significantly affected medical costs (P<0.001). For inpatients, age and complications and treatment effect were influential factors (P<0.05). Patients with the combined skeletal system and central nervous system complications had significantly higher medical costs (P<0.001). Conclusions The medical costs for outpatient cases of Brucellosis were moderate. However, the economic burden was higher for inpatients, especially those with skeletal and neurological complications. Early detection, diagnosis, and treatment of cases were essential to avoid chronic Brucellosis and its complications and reduce medical costs. |
|
查看全文
Html全文
查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|
